Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 26.13B | 23.62B | 22.37B | 20.87B | 18.47B |
Gross Profit | 10.77B | 9.79B | 9.57B | 8.99B | 7.88B |
EBITDA | 3.28B | 3.09B | 3.29B | 3.67B | 3.26B |
Net Income | 1.69B | 1.69B | 1.92B | 2.11B | 1.83B |
Balance Sheet | |||||
Total Assets | 41.05B | 42.82B | 40.84B | 36.89B | 34.69B |
Cash, Cash Equivalents and Short-Term Investments | 11.69B | 13.41B | 16.17B | 12.40B | 11.69B |
Total Debt | 0.00 | 8.86M | 7.40M | 1.16M | 2.89M |
Total Liabilities | 5.55B | 8.40B | 8.26B | 5.85B | 5.49B |
Stockholders Equity | 35.11B | 34.07B | 32.28B | 30.79B | 28.96B |
Cash Flow | |||||
Free Cash Flow | -985.94M | -225.33M | 4.30B | 1.24B | 3.34B |
Operating Cash Flow | -377.69M | 119.09M | 4.61B | 2.08B | 3.49B |
Investing Cash Flow | -129.64M | -2.52B | -299.61M | -1.34B | -1.99B |
Financing Cash Flow | -720.50M | -1.07B | -695.63M | -763.64M | -561.05M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥21.78B | 13.11 | 3.15% | 5.39% | -0.34% | ||
79 Outperform | $37.21B | 10.39 | 9.67% | 3.03% | -1.43% | -6.49% | |
73 Outperform | $4.47T | 36.03 | 28.07% | 0.94% | 19.04% | 30.11% | |
71 Outperform | ¥269.83B | 15.10 | 8.31% | 2.77% | 6.08% | 11.04% | |
69 Neutral | ¥13.92B | 7.10 | 2.14% | 65.63% | 103.99% | ||
67 Neutral | $376.24B | 30.32 | 4.68% | 2.54% | 4.14% | 33.45% | |
66 Neutral | €112.28B | 62.25 | 2.62% | 1.33% | -1.62% | -81.26% |